Characterization of [3H]AZ12464237 as a high affinity, non-nucleotide antagonist radioligand for the P2Y12 receptor

Stéen, E. Johanna L. and Tousiaki, Efthalia-Natalia and Kingston, Lee and van der Wildt, Berend and Lénárt, Nikolett and Beaino, Wissam and Verlaan, Mariska and Zarzycka, Barbara and Zinnhardt, Bastian and Dénes, Ádám and Gobbi, Luca and de Esch, Iwan J.P. and Elmore, Charles S. and Windhorst, Albert D. and Honer, Michael and Leurs, Rob (2025) Characterization of [3H]AZ12464237 as a high affinity, non-nucleotide antagonist radioligand for the P2Y12 receptor. BIOCHEMICAL PHARMACOLOGY, 237. ISSN 0006-2952

Preview	Text Characterizationof3HAZ12464237asahighaffinitynon-nucleotideantagonist....pdf - Published Version Available under License Creative Commons Attribution. Download (9MB) | Preview
Preview	Text 1-s2.0-S0006295225001625-ga1_lrg.jpg - Published Version Available under License Creative Commons Attribution. Download (77kB) | Preview

Abstract

The purinergic receptor P2Y12 (P2Y12R) is a well-recognized target for anti-thrombotic agents. This receptor is also expressed in microglia, the main immune cells of the brain, where it modulates microglial activation states and inflammatory responses. To investigate P2Y12R-mediated actions in the central nervous system (CNS), developing novel brain-penetrant ligands and further in vitro studies on brain tissues are essential. A radiolabeled, easily accessible tool compound would significantly advance such drug discovery efforts. Herein, we describe the 3H-labeling of a non-nucleotide P2Y12R antagonist AZ12464237, and its in vitro binding properties to the receptor in membrane preparations from transfected cells, as well as on mouse brain tissues. The radioligand shows high affinity toward both the human and rat P2Y12R, with Kd values of 3.12 ± 0.70 nM (human) and 16.6 ± 3.40 nM (rat), as determined by saturation binding studies. The binding kinetics of [3H]AZ12464237 are rapid with a short target residence time (∼1 min). We further confirmed the selectivity of the radioligand by performing competitive displacement studies, in which reported P2Y12R ligands and other P2Y receptors ligands were tested for binding against [3H]AZ12464237. Additionally, the radioligand proved valuable for in vitro autoradiography studies on mouse brain tissues, although limited off-target binding was observed in P2Y12R knock-out mouse brain. This could be traced to glycogen synthase kinase 3 α. Considering the growing interest in P2Y12R as a biomarker for anti-inflammatory microglia, [3H]AZ12464237 represents a promising tool for in vitro studies, including screening assays aimed at identifying novel P2Y12R ligands for CNS applications.

Actions (login required)

Edit Item